PBE
NYSE
$89.68
INVESCO BIOTECHNOLOGY & GENOME ETF (PBE)
Sector:
Healthcare
Net assets
$278M
Inception date
June 23, 2005
Expense ratio
0.58%
Sharpe Ratio
1.65
Price Chart
Valuation
Net assets$278M
P/E35.63
Forward P/E19.97
P/S4.60
P/B4.42
Profitability
Profit Margin30.3%
Operating Margin13.2%
Financial Health
Debt-to-Equity69.5%
Growth & Risk
EPS 5Y CAGR+10.60%
Revenue 5Y CAGR+19.98%
FCF 5Y CAGR+13.20%
Beta (5Y)0.73
Sharpe Ratio1.65